Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SUD Regulations Mulled In Senate; Hospitals May Not Be Complying

This article was originally published in The Gray Sheet

Executive Summary

Senate HELP Committee Chairman Edward Kennedy (D-Mass.) supports efforts to provide stronger control of reprocessed single-use medical devices (SUDs), but he has not committed to folding tighter requirements for reprocessors in the conference report on the Bioterrorism Preparedness Act of 2001 (S 1795)

You may also be interested in...



MedWatch Form To Include SUD Info; FDA Surveys Hospital Reprocessing

FDA will have to modify MedWatch forms to make reporting adverse events for reprocessed single-use devices easier, under a new reuse provision in the "Medical Device User Fee & Modernization Act.

MedWatch Form To Include SUD Info; FDA Surveys Hospital Reprocessing

FDA will have to modify MedWatch forms to make reporting adverse events for reprocessed single-use devices easier, under a new reuse provision in the "Medical Device User Fee & Modernization Act.

FDA Bypass Budget, Separation From Ag Approps Suggested By Hatch

A proposal that would allow FDA to submit its budget request directly to the congressional panels responsible for funding the agency currently is being explored in the Senate by Sens. Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel